We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CERTAIN COMBO PRODUCTS SUBJECT TO cGMP, QS RULES
CERTAIN COMBO PRODUCTS SUBJECT TO cGMP, QS RULES
October 6, 2004
Companies that manufacture single-entity or co-packaged combination products must adhere to manufacturing regulations governing both pharmaceutical products and medical devices, according to a draft guidance released Sept. 29 as part of the FDA’s pharmaceutical cGMP initiative.